scholar.google.com › citations
Oct 28, 2020 · Palbociclib (PD0332991) is a specific CDK4/6 inhibitor that arrests cell cycle progression in proliferating tumor cells, and tumors lacking RB1 ...
People also ask
What is the function of the cyclin-CDK complex?
What do CDK inhibitors do?
What are the cyclin kinase inhibitor proteins?
What are the two groups of CDK inhibitors?
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes ... - NCBI
www.ncbi.nlm.nih.gov › PMC6047232
In this study, we examined the antiproliferative effects of the cyclin-dependent kinase inhibitor dinaciclib in malignant human glioma cell lines, with intact, ...
Abstract. Cyclin-dependent kinases (CDK) are key positive regulators of cell cycle progression and attractive targets in oncology. SCH 727965 inhibits.
The inhibition of ATP stops the activation of the cyclinE/CDK2 complex, which puts a halt to cell cycle progression. The appropriate regulation of this protein ...
People also search for
Feb 12, 2008 · General Features of Cip/Kip Proteins. Progression through the cell-division cycle is regulated by the coordinated activities of cyclin/cyclin- ...
p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2- ...
MW 396.5 Da, Purity >98%. Novel, potent, selective cyclin-dependent kinase (CDK) inhibitor displaying selectivity for CDK1, CDK2, CDK5 and CDK9 (IC50 values ...
Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed:9106657). Involved in p53/TP53 mediated inhibition of ...